Patent · US Active

4-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection

US9856247B2 · kind B2 · utility

0Cited by

12References

18Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Lei Guo · Kowloon, CN
Xianfeng Lin · Shanghai, CN
Haixia Liu · Shanghai, CN
Zongxing Qiu · Shanghai, CN
Hong Sheng · Shanghai, CN
Guozhi Tang · Shanghai, CN
Guolong Wu · Shanghai, CN
Weixing Zhang · Shanghai, CN
Wei Zhu · Shanghai, CN

Key dates

Filing date	Aug 28, 2015
Grant date	Jan 2, 2018
Priority date	—
Expiry date	Aug 28, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention provides novel compounds having the general formula:wherein R1, R2, R3, R4, R5, M and X are as described herein, compositions including the compounds and methods of using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.